Biosimilars: Company Strategies to Capture Value from the Biologics Market

Patents for several biologic blockbusters will expire in the next few years. The arrival of biosimilars, the biologic equivalent of chemical generics, will have an impact on the current biopharmaceuticals market. Five core capabilities have been identified as paramount for those companies aiming to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Juan Leonardo Martínez-Hurtado (Author), Bruno Calo-Fernández (Author)
Formato: Livro
Publicado em: MDPI AG, 2012-12-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Área/Cota: A1234.567
Cód. Barras: 1 Disponível